...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Toxicity

Sure would like to see a science update from Zenith with 12 trials going on now.

tada

 

Share
New Message
Please login to post a reply